National Brain Tumor Society
The National Brain Tumor Society, founded in 2008 and based in Newton, Massachusetts, is a non-profit organization dedicated to advancing the understanding and treatment of brain tumors. It focuses on discovering cures, delivering effective treatments, and advocating for the needs of patients and their caregivers. By mobilizing and uniting the brain tumor community, the organization aims to foster collaboration among researchers, healthcare professionals, and advocates to improve outcomes for those affected by brain tumors. Through its initiatives, the Society seeks to enhance awareness and drive critical research efforts in the field of neuro-oncology.
Top Stages
3 past transactions
Modifi Bio
Seed Round in 2023
Modifi Biosciences specializes in direct DNA modification and the development of innovative cancer therapeutics. The company focuses on a unique strategy that involves altering tumor DNA to make cancer cells irreparable, while ensuring that healthy cells remain unharmed. This approach allows researchers to challenge and advance traditional methods of oncology drug development, potentially leading to more effective treatments for a variety of cancers. By exploiting DNA defects found in cancer cells, Modifi Biosciences aims to contribute significantly to the field of cancer research and therapy.
Modifi Bio
Seed Round in 2022
Modifi Biosciences specializes in direct DNA modification and the development of innovative cancer therapeutics. The company focuses on a unique strategy that involves altering tumor DNA to make cancer cells irreparable, while ensuring that healthy cells remain unharmed. This approach allows researchers to challenge and advance traditional methods of oncology drug development, potentially leading to more effective treatments for a variety of cancers. By exploiting DNA defects found in cancer cells, Modifi Biosciences aims to contribute significantly to the field of cancer research and therapy.
Alpheus Medical
Series A in 2021
Alpheus Medical develops a sonodynamic therapy platform for solid tumors, combining a drug with a device activated by ultrasound to deliver targeted treatment for recurrent glioblastoma multiforme and other cancers. The non-invasive outpatient approach aims to avoid imaging and hospital admission while concentrating therapy on malignant tissues.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.